2,572
Views
8
CrossRef citations to date
0
Altmetric
Case Report

Intranasal melanoma treated with radiation therapy in three dogs

, , , , , & show all
Pages 274-281 | Received 30 Nov 2016, Accepted 30 Sep 2017, Published online: 10 Nov 2017

References

  • Adams WM, Bjorling DE, McAnulty JE, Green EM, Forrest LJ, Vail DM. 2005. Outcome of accelerated radiotherapy alone or accelerated radiotherapy followed by exenteration of the nasal cavity in dogs with intranasal neoplasia: 53 cases (1990–2002). J Am Vet Med Assoc. 227(6):936–941.
  • Bateman KE, Catton PA, Pennock PW, Kruth SA. 1994. 0-7-21 Radiation therapy for the treatment of canine oral melanoma. J Vet Intern Med. 8(4):267–272.
  • Busam KJ, Jungbluth AA. 1999. Melan-A, a new melanocytic differentiation marker. Adv Anat Pathol. 6(1):12–18.
  • Choi C, Kusewitt DF. 2003. Comparison of tyrosinase-related protein-2, S-100, and Melan A immunoreactivity in canine amelanotic melanomas. Vet Pathol. 40(6):713–718.
  • Esplin DG. 2008. Survival of dogs following surgical excision of histologically well-differentiated melanocytic neoplasms of the mucous membranes of the lips and oral cavity. Vet Pathol. 45:889–896.
  • Freeman KP, Hahn KA, Harris FD, King GK. 2003. Treatment of dogs with oral melanoma by hypofractionated radiation therapy and platinum-based chemotherapy (1987–1997). J Vet Intern Med. 17(1):96–101.
  • Fujita M, Takaishi Y, Yasuda D, Hasegawa D, Taniguchi A, Takahashi K, Orima H. 2008. Intranasal hemangiosarcoma in a dog. J Vet Med Sci. 70(5):525–528.
  • Fujiwara A, Kobayashi T, Kazato Y, Yayoshi N, Fujita M. 2013. Efficacy of hypofractionated radiotherapy for nasal tumours in 38 dogs (2005–2008). J Small Anim Pract. 54(2):80–86.
  • Giudice C, Ceciliani F, Rondena M, Stefanello D, Grieco V. 2010. Immunohistochemical investigation of PNL2 reactivity of canine melanocytic neoplasms and comparison with Melan A. J Vet Diagn Invest. 22:389–394.
  • Gouldesbrough D, Martin-Hirsch D, Lannigan F. 1992. Intranasal malignant melanoma arising in an inverted papilloma. Histopathology. 20:523–526.
  • Hicks DG, Fidel JL. 2006. Intranasal malignant melanoma in a dog. J Am Anim Hosp Assoc. 42(6):472–476.
  • Kawabe M, Mori T, Ito Y, Murakami M, Sakai H, Yanai T, Maruo K. 2015. Outcomes of dogs undergoing radiotherapy for treatment of oral malignant melanoma : 111 cases (2006–2012). J Am Vet Med Assoc. 247(10):1146–1153.
  • Koenig A, Wojcieszyn J, Weeks BR, Modiano JF. 2001. Expression of S100a, vimentin, NSE, and melan A/MART-1 in seven canine melanoma cells lines and twenty-nine retrospective cases of canine melanoma. Vet Pathol. 38:427–435.
  • Kubicek L, Milner R, An Q, Kow K, Chang M, Cooke K, Fox L, Farese J, Bacon N, Lurie D. 2016. Outcomes and prognostic factors associated with canine sinonasal tumors treated with curative intent cone-based stereotactic radiosurgery (1999–2013). Vet Radiol Ultrasound. 57(3):331–340.
  • Lana SE, Dernell WS, Lafferty MH, Withrow SJ, LaRue SM. 2004. Use of radiation and a slow-release cisplatin formulation for treatment of canine nasal tumors. Vet Radiol Ultrasound. 45(6):577–581.
  • Lawrence JA, Forrest LJ, Turek MM, Miller PE, Mackie TR, Jaradat HA, Vail DM, Dubielzig RR, Chappell R, Mehta MP. 2010. Proof of principle of ocular sparing in dogs with sinonasal tumors treated with intensity-modulated radiation therapy. Vet Radiol Ultrasound. 51(5):561–570.
  • Lin C, Yang S, Lai C. 2003. Primary malignant melanoma of the nasal cavity. Chang Gung Med J. 26(11):857–862.
  • Madewell B, Priester W, Gillette E. 1976. Neoplasms of the nasal passages and paranasal sinuses in domesticated animals as reported by 13 veterinary colleges. Am J Vet Res. 37(7):851–856.
  • Martinez CM, Penafiel-Verdu C, Vilafranca M, Ramirez G, Mendez-Gallego M, Buendia, AJ, Sanchez J. 2011. Cyclooxygenase-2 expression is related with localization, proliferation, and overall survival in canine melanocytic neoplasms. Vet Pathol. 48(6):1204–1211.
  • Millanta F, Fratini F, Corazza M, Castagnaro M, Zappulli V, Poli A. 2002. Proliferation activity in oral and cutaneous canine melanocytic tumours: Correlation with histological parameters, location, and clinical behaviour. Res Vet Sci. 73(1):45–51.
  • Morris JS, Dunn JK, Dobson JM, White RAS. 1994. Effects of radiotherapy alone and surgery and radiotherapy on survival of dogs with nasal tumours. J Small Anim Pract. 35(11):567–573.
  • Murphy S, Hayes AM, Blackwood L, Maglennon G, Pattinson H, Sparkes AH. 2005. Oral malignant melanoma – the effect of coarse fractionation radiotherapy alone or with adjuvant carboplatin therapy. Vet Comp Oncol. 3(4):222–229.
  • Naganobu K, Ogawa H, Uchida K, Yamaguchi R, Ohashi F, Kubo K, Aoki M, Kuwamura M, Ogawa Y, Matsuyama K. 2000. Mast cell tumour in the nasal cavity of a dog. J Vet Med Sci. 62(9):1009–1011.
  • Papazoglou LG, Koutinas AF, Plevraki AG, Tontis D. 2001. Primary intranasal transmissible venereal tumour in the dog: a retrospective study of six spontaneous cases. J Vet Med A. 48(7):391–400.
  • Patnaik A. 1989. Canine sinonasal neoplasms: clinicopathological study of 285 cases. J Am Anim Hosp Assoc. 25:103–114.
  • Peryaga G, Lafond C, Pointreau Y, Giraud P, Maingon P. 2016. Nasal cavity and paransal sinus cancer. Cancer Radiother. 20:S99–103.
  • Pinard CL, Mutsaers AJ, Mayer MN, Paul Woods J. 2012. Retrospective study and review of ocular radiation side effects following external-beam Cobalt-60 radiation therapy in 37 dogs and 12 cats. Can Vet J. 53(12):1301–1307.
  • Proulx DR, Ruslander DM, Dodge RK, Hauck ML. 2003. A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation. Vet Radiol Ultrasound. 44(3):352–359.
  • Rabanal R, Fondevila DM, Montané V, Domingo M, Ferrer L. 1989. Immunocytochemical diagnosis of skin tumours of the dog with special reference to undifferentiated types. Res Vet Sci. 47(1):129–133.
  • Ramos-Vara JA, Beissenherz ME, Miller MA, Johnson GC, Pace LW, Fard A, Kottler SJ. 2000. Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases. Vet Pathol. 37(6):597–608.
  • Ramos-Vara JA, Miller MA. 2011. Immunohistochemical identification of canine melanocytic neoplasms with antibodies to melanocytic antigen PNL2 and tyrosinase: comparison with Melan A. Vet Pathol. 48:443–450.
  • Smedley RC, Spangler WL, Esplin DG, Kitchell BE, Bergman PJ, Ho HY, Bergin IL, Kiupel M. 2011. Prognostic markers for canine melanocytic neoplasms: a comparative review of the literature and goals for future investigation. Vet Pathol. 48(1):54–72.
  • Smith SH, Goldschmidt MH, McManus PM. 2002. A comparative review of melanocytic neoplasms. Vet Pathol. 39(6):651–678.
  • Spangler WL, Kass PH. 2006. The histologic and epidemiologic bases for prognostic considerations in canine melanocytic neoplasia. Vet Pathol. 43(2):136–149.
  • Théon A, Madewell BR, Harb MF, Dungworth DL. 1993. Megavoltage irradiation of neoplasms of the nasal and paranasal cavities in 77 dogs. J Am Vet Med Assoc. 202(9):1469–1475.
  • Tuohy JL, Selmic LE, Worley DR, Ehrhart NP, Withrow SJ. 2014. Outcome following curative-intent surgery for oral melanoma in dogs : 70 cases (1998–2011). J Am Vet Med Assoc. 245(11):1266–1273.
  • Ueno H, Kobayashi Y, Yamada K. 2007. Olfactory esthesioneuroblastoma treated with orthovoltage radiotherapy in a dog. Aust Vet J. 85(7):271–275.
  • Williams LE, Packer RA. 2003. Association between lymph node size and metastasis in dogs with oral malignant melanoma: 100 cases (1987–2001). J Am Vet Med Assoc. 222(9):1234–1236.